0 results for 'AstraZeneca'
Litigator of the Week Runners-Up and Shout-Outs
Willkie Farr & Gallagher scored a major win at the Third Circuit for bondholders in the bankruptcy of Hertz Corp. entitling them to nearly $270 million plus interest.
Chancery Again Rules in Plaintiff's Favor in Earnout Provision Dispute
Alexion Pharmaceuticals Inc. could later be ordered to pay more in damages for another claim in which Zurn ruled against it, but Alexion's counterclaim against Shareholder Representative Services, represented by Quinn Emanuel Urquhart & Sullivan, is yet to be decided. Alexion is represented by Wilks Law and Arnold & Porter Kaye Scholer.
Tom Sabatino, an 8-Time Legal Chief, Off to New Adventures After Year-Long Run at Rite Aid
Sabatino helped the pharmacy chain navigate its way through a Chapter 11 bankruptcy restructuring that slashed its debt load.
Litigation Leaders: Adam Siegel of Freshfields on Four 'Cs' of the Firm's Litigation Practice
Siegel, who joined Freshfields Bruckhaus Deringer more than 15 years ago to help start its white-collar practice in the U.S., says the words "commercial," "creativity," "collegiality" and "cross-border" are "core" to the firm's litigation department.
Law Journal Press | Digital Book
Florida Construction Defect Litigation 2025
Authors: Gary L. Brown
View this Book
View more book results for the query "AstraZeneca"
Litigator of the Week Runners-Up and Shout-Outs
A team at Covington & Burling knocked out a $107.5 million patent infringement verdict facing pharmaceutical client AstraZeneca.
Covington Defeats Jones Day: AstraZeneca Escapes $107.5M Verdict
AstraZeneca prevailed on its argument that patents-in-suit are invalid because they are not enabled on the issue of unit dosage.
NJ's Top Personal Injury Awards Total Nearly $654M
The awards this year totaled about $654 million, which is much higher than last year's total of $169.3 million, and which makes the average award this year $32.7 million.
Litigation Leaders: Covington's John Hall on the Value of Specialization
Hall says that perhaps a generalist approach to litigation works at firms where litigators mostly support larger transactional practices. "But at Covington, our litigation practice is a huge driver of new client work and relationships," he said.
Boehringer Ingelheim Pharmaceuticals Loses Challenge to Inflation Reduction Act
"We are disappointed by this ruling and what it means for biopharmaceutical innovation," the company said. "Boehringer Ingelheim shares the goal of ensuring our medicines are affordable and available to people who need them. However, we remain concerned about the detrimental and limiting effects the IRA and its 'negotiation' program will have on the future of innovation for the patients we serve."Trending Stories
- 1Ex-Prosecutor and Judge Fatally Shot During Attempted Arrest on Federal Corruption Charges
- 2'I'm Staying Everything': Texas Bankruptcy Judge Halts Talc Trials Against J&J
- 3The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 4NYC Mayor Eric Adams Indicted on Public Corruption Allegations
- 5What We Know About the Kentucky Judge Killed in His Chambers
Featured Firms
More from ALM
- Morgan & Morgan Class Action Attorneys Detail Pathway to Success Within Cybersecurity and Data Privacy Practice 1 minute read
- Holwell Shuster & Goldberg Partners Leverage 'Hostile' Witnesses to Secure $101 Million Verdict Against Walmart 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
Resources
2024 Trends Report Mid-Year Special Edition: Update on Outside Counsel Billing Rates
Brought to you by LexisNexis® CounselLink®
Download Now
AI in Private Equity: A Guide for Gaining an Early Advantage
Brought to you by Ontra
Download Now
Why Are So Many Law Firms Suddenly Embracing Digital Transformation?
Brought to you by AllRize
Download Now
2025 State Legislative Sessions
Brought to you by LexisNexis®
Download Now